Gail Visit 2: Improving Quality of Life for Patients with Overactive Bladder
| Title: | Gail Visit 2: Improving Quality of Life for Patients with Overactive Bladder |
| Topic: | Urology |
| Relevant Terms: | Overactive Bladder |
| Primary Audience: | Physicians; Pharmacists; Physician Assistants; Nurse Practitioners; Nurse Midwives and other professionals. |
| Launch Date: | 29-Nov-11 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ 0.5 ACPE contact hour 0.5 NPWH contact hour (including 0.25 pharmacology hour) |
| Expiration Date: | 28-Nov-12 |
| Curriculum Name: | Improving Quality of Life for Patients with Overactive Bladder |
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Demonstrate effective counseling skills in order to facilitate conversation about OAB with appropriate patients
- Provide guidance regarding pharmacological and non-pharmacological treatments, emphasizing adherence
- Manage treatment side effects to provide best outcome for patients
- Develop strategies for patient centered care, including referral when indicated
Faculty
Disclosure Policy Statement
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Faculty Disclosures
Pharmacists: The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.5 contact hours of continuing education credit. The assigned universal program number for this program is 0463-0000-11-005-H01-P.

Others: A certificate of participation will be issued indicating that this activity is accredited for up to 0.5 hours of AMA PRA Category 1 Credit™.
How to Receive Credit or a Certificate of Participation
Course Viewing Requirements
Commercial Support
This project is funded through an educational grant from Allergan, Inc., Astellas Pharma Inc., Pfizer, and Teva Pharmaceuticals.



All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).


All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Faculty Disclosures
- Amy Park has nothing to disclose.
- Anne Moore has nothing to disclose.
- Deborah Kurnik, Ellen Cohen, Cert.Ed., Dip.Ed., CCMEP, Beth Jordan, MD, Camille Harris, MPH, Amy Swann, MA, Shana Brown, MPH, Rebecca Sager and Wayne Shields have no affiliations to disclose.
Credit Designation
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses: This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 0.5 contact hours, including up to 0.25 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses: This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 0.5 contact hours, including up to 0.25 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Pharmacists: The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 0.5 contact hours of continuing education credit. The assigned universal program number for this program is 0463-0000-11-005-H01-P.
Others: A certificate of participation will be issued indicating that this activity is accredited for up to 0.5 hours of AMA PRA Category 1 Credit™.
How to Receive Credit or a Certificate of Participation
- Read the learning objectives and disclosures
- Participate in the activity
- Complete the post-test and activity evaluation
- You must score a 65% or higher on the post-test and activity evaluation
- Statement of credit will be available to print from your user history page
Course Viewing Requirements
| PC Internet Explorer (v6 or greater), or Firefox |
MAC Safari |
Commercial Support
This project is funded through an educational grant from Allergan, Inc., Astellas Pharma Inc., Pfizer, and Teva Pharmaceuticals.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/).



